Published in Transl Stroke Res on April 17, 2012
P2X7 receptor antagonism inhibits p38 mitogen-activated protein kinase activation and ameliorates neuronal apoptosis after subarachnoid hemorrhage in rats. Crit Care Med (2013) 1.76
Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage. J Cereb Blood Flow Metab (2014) 1.00
Should the STAIR criteria be modified for preconditioning studies? Transl Stroke Res (2013) 0.83
Brain CD47 expression in a swine model of intracerebral hemorrhage. Brain Res (2014) 0.83
Transient ischemia elicits a sustained enhancement of thrombus development in the cerebral microvasculature: effects of anti-thrombotic therapy. Exp Neurol (2014) 0.81
Astrocyte overexpression of heme oxygenase-1 improves outcome after intracerebral hemorrhage. Stroke (2015) 0.80
Hyperbaric oxygen preconditioning: a reliable option for neuroprotection. Med Gas Res (2016) 0.75
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82
[Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol (1957) 12.36
Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol (2006) 6.06
Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci (2006) 4.51
Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet (2003) 3.36
Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke (2003) 2.71
Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg (2004) 2.31
Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke (1998) 2.25
Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke (1999) 2.00
Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol (1999) 1.93
Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg (2006) 1.82
Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ (2008) 1.65
Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology (1999) 1.54
Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration. Stroke (2009) 1.36
Iron and iron management proteins in neurobiology. Pediatr Neurol (2001) 1.18
Intracerebral hirudin injection attenuates ischemic damage and neurologic deficits without altering local cerebral blood flow. J Cereb Blood Flow Metab (2004) 1.10
Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat. J Cereb Blood Flow Metab (2001) 1.06
Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron. J Cereb Blood Flow Metab (2003) 1.04
Effects of cerebral ischemia on neuronal hemoglobin. J Cereb Blood Flow Metab (2008) 1.03
Is there a place for cerebral preconditioning in the clinic? Transl Stroke Res (2010) 0.96
Preconditioning with hyperbaric oxygen attenuates brain edema after experimental intracerebral hemorrhage. Neurosurg Focus (2007) 0.95
Pharmacologic preconditioning: translating the promise. Transl Stroke Res (2010) 0.89
Activation of p44/42 mitogen activated protein kinases in thrombin-induced brain tolerance. Brain Res (2001) 0.89
Protective mechanism of preconditioning hypoxia attenuates apoptosis formation during renal ischemia/reperfusion phase. Transplant Proc (1999) 0.84
Effects of cervical spinal cord stimulation on cerebral blood flow in the rat. J Neurosurg (2000) 0.82
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol (2006) 6.06
Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke (2003) 2.71
Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol (2012) 2.62
Behavioral tests after intracerebral hemorrhage in the rat. Stroke (2002) 2.46
Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab (2005) 2.45
Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg (2002) 2.40
Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg (2004) 2.31
Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J Cell Sci (2003) 2.21
Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke (2007) 2.02
Role of iron in brain injury after intraventricular hemorrhage. Stroke (2010) 1.91
Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg (2006) 1.82
Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke (2009) 1.72
The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem (2003) 1.69
Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke (2007) 1.68
Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke (2009) 1.65
Pathophysiology of brain edema formation. Neurosurg Clin N Am (2002) 1.50
Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J Cereb Blood Flow Metab (2006) 1.49
Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury. J Cereb Blood Flow Metab (2010) 1.46
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J Immunol (2006) 1.44
Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage. Neurosurgery (2009) 1.43
Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J Biol Chem (2009) 1.42
Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J Biol Chem (2006) 1.40
Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res (2002) 1.39
Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol (2008) 1.38
Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration. Stroke (2009) 1.36
Intracerebral hemorrhage in mice: model characterization and application for genetically modified mice. J Cereb Blood Flow Metab (2004) 1.35
Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery (2006) 1.35
Intracerebral hemorrhage: effects of aging on brain edema and neurological deficits. Stroke (2004) 1.35
Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. J Cereb Blood Flow Metab (2003) 1.35
Subarachnoid hemorrhage-induced hydrocephalus in rats. Stroke (2012) 1.33
A new hippocampal model for examining intracerebral hemorrhage-related neuronal death: effects of deferoxamine on hemoglobin-induced neuronal death. Stroke (2007) 1.31
Peptide and peptide analog transport systems at the blood-CSF barrier. Adv Drug Deliv Rev (2004) 1.31
Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke (2007) 1.30
Oxidative DNA injury after experimental intracerebral hemorrhage. Brain Res (2005) 1.30
The deleterious or beneficial effects of different agents in intracerebral hemorrhage: think big, think small, or is hematoma size important? Stroke (2005) 1.24
Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia. Stroke (2010) 1.22
Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation. J Neurosci (2002) 1.21
Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice. J Pharmacol Exp Ther (2005) 1.19
Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke (2011) 1.19
Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab Dispos (2007) 1.19
Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke (2007) 1.16
Effect of sustained-mild and transient-severe hyperglycemia on ischemia-induced blood-brain barrier opening. J Cereb Blood Flow Metab (2007) 1.15
Effects of thrombin on neurogenesis after intracerebral hemorrhage. Stroke (2008) 1.15
Autophagy after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab (2007) 1.13
Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol Pharm (2005) 1.12
Mechanisms of hydrocephalus after neonatal and adult intraventricular hemorrhage. Transl Stroke Res (2012) 1.11
Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity. J Neurochem (2007) 1.11
Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res (2013) 1.10
Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus. J Biol Chem (2002) 1.10
Intracerebral hirudin injection attenuates ischemic damage and neurologic deficits without altering local cerebral blood flow. J Cereb Blood Flow Metab (2004) 1.10
Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage. Stroke (2011) 1.08